Business Description
Jasper Therapeutics is a Redwood City, California-based biotech company founded in 2018 that is working to bring new treatments to patients suffering from conditions driven by mast cells and blood stem cells. Its main drug candidate, briquilimab, is an antibody that interrupts a key biological signal used by these cells to grow and function. The company is pursuing treatments for conditions such as chronic hives and asthma, while also exploring how its approach could help prepare patients with serious blood disorders for stem cell transplants.
